{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T20:51:04Z","timestamp":1723582264735},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,7,27]],"date-time":"2014-07-27T00:00:00Z","timestamp":1406419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12185-014-1634-7","type":"journal-article","created":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T04:55:44Z","timestamp":1406350544000},"page":"290-295","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)\/Rai stage 0 chronic lymphocytic leukemia (CLL)"],"prefix":"10.1007","volume":"100","author":[{"given":"Stefano","family":"Molica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Levato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Lentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,27]]},"reference":[{"issue":"12","key":"1634_CR1","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute\u2014Working Group 1996 guidelines. Blood. 2008;111(12):5446\u201356.","journal-title":"Blood"},{"issue":"19","key":"1634_CR2","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019\u201332.","journal-title":"Blood"},{"issue":"19","key":"1634_CR3","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2012-01-404681","volume":"119","author":"P Ghia","year":"2012","unstructured":"Ghia P, Caligaris-Cappio F. Monoclonal B-cell lymphocytosis: right track or red herring? Blood. 2012;119(19):4358\u201362.","journal-title":"Blood"},{"issue":"18","key":"1634_CR4","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1182\/blood-2008-09-176149","volume":"113","author":"TD Shanafelt","year":"2009","unstructured":"Shanafelt TD, Kay NE, Jenkins G, et al. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood. 2009;113(18):4188\u201396.","journal-title":"Blood"},{"issue":"6","key":"1634_CR5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","volume":"359","author":"AC Rawstron","year":"2008","unstructured":"Rawstron AC, Bennett FL, O\u2019Connor SJ, Kwok M, Fenton JA, Plummer M, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359(6):575\u201383.","journal-title":"N Engl J Med"},{"issue":"22","key":"1634_CR6","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2012-12-471698","volume":"121","author":"A Vardi","year":"2013","unstructured":"Vardi A, Dagklis A, Scarfo L, et al. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. Blood. 2013;121(22):4521\u20138.","journal-title":"Blood"},{"issue":"2","key":"1634_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3324\/haematol.2010.030189","volume":"96","author":"S Molica","year":"2011","unstructured":"Molica S, Mauro FR, Giannarelli D, et al. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica. 2011;96(2):277\u201383.","journal-title":"Haematologica"},{"issue":"6","key":"1634_CR8","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/10428190701321277","volume":"48","author":"SS Fung","year":"2007","unstructured":"Fung SS, Hillier KL, Leger CS, et al. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis. Leuk Lymphoma. 2007;48(6):1087\u201391.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1634_CR9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","volume":"146","author":"D Rossi","year":"2009","unstructured":"Rossi D, Sozzi E, Puma A, et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol. 2009;146(1):64\u201375.","journal-title":"Br J Haematol"},{"issue":"7","key":"1634_CR10","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/leu.2012.20","volume":"26","author":"L Scarfo","year":"2012","unstructured":"Scarfo L, Zibellini S, Tedeschi A, et al. Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? Leukemia. 2012;26(7):1703\u20137.","journal-title":"Leukemia"},{"issue":"19","key":"1634_CR11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2011.09010.x","volume":"157","author":"W Kern","year":"2012","unstructured":"Kern W, Bacher U, Haferlach C, et al. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL. Br J Haematol. 2012;157(19):86\u201396.","journal-title":"Br J Haematol"},{"issue":"2","key":"1634_CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hoc.2013.01.004","volume":"27","author":"L Scarf\u00f2","year":"2013","unstructured":"Scarf\u00f2 L, Fazi C, Ghia P. MBL versus CLL: how important is the distinction? Hematol Oncol Clin North Am. 2013;27(2):251\u201365.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3","key":"1634_CR13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood-2002-12-3639","volume":"102","author":"A Guarini","year":"2003","unstructured":"Guarini A, Gaidano G, Mauro FR, et al. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood. 2003;102(3):1035\u201341.","journal-title":"Blood"},{"issue":"21","key":"1634_CR14","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1158\/1078-0432.CCR-13-0622","volume":"19","author":"F Morabito","year":"2013","unstructured":"Morabito F, Mosca L, Cutrona G, et al. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: a comparison of cellular, cytogenetic, molecular, and clinical features. Clin Cancer Res. 2013;19(21):5890\u2013900.","journal-title":"Clin Cancer Res"},{"issue":"31","key":"1634_CR15","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1200\/JCO.2010.33.9002","volume":"29","author":"WG Wierda","year":"2011","unstructured":"Wierda WG, O\u2019Brien S, Wang X, et al. Multivariate model for time to first treatment in patients with chronic lymphocytic leukemia. J Clin Oncol. 2011;29(31):4088\u201395.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1634_CR16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/cncr.27900","volume":"119","author":"S Molica","year":"2013","unstructured":"Molica S, Giannarelli D, Gentile M, et al. External validation on a prospective basis of a nomogram for predicting time to first treatment in patients with chronic lymphocytic leukemia. Cancer. 2013;119(6):1177\u201385.","journal-title":"Cancer"},{"issue":"3","key":"1634_CR17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.2830290307","volume":"29","author":"BD Cheson","year":"1988","unstructured":"Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am J Hematol. 1988;29(3):152\u201363.","journal-title":"Am J Hematol"},{"issue":"12","key":"1634_CR18","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"BD Cheson","year":"1996","unstructured":"Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O\u2019Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87(12):4990\u20137.","journal-title":"Blood"},{"issue":"6","key":"1634_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3324\/haematol.11646","volume":"93","author":"G Cutrona","year":"2008","unstructured":"Cutrona G, Colombo M, Matis S, et al. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells. Haematologica. 2008;93(6):413\u201322.","journal-title":"Haematologica"},{"issue":"8","key":"1634_CR20","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","volume":"102","author":"F Fais","year":"1998","unstructured":"Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102(8):1515\u201325.","journal-title":"J Clin Invest."},{"issue":"9","key":"1634_CR21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/gcc.20579","volume":"47","author":"S Fabris","year":"2008","unstructured":"Fabris S, Mosca L, Todoerti K, et al. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2008;47(9):781\u201393.","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"1634_CR22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.leukres.2006.07.006","volume":"31","author":"VA Hoffbrand","year":"2007","unstructured":"Hoffbrand VA, Hamblin TJ. Is \u201cleukemia\u201d an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia? Leuk Res. 2007;31(3):273\u20135.","journal-title":"Leuk Res"},{"issue":"1","key":"1634_CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3324\/haematol.2011.053090","volume":"97","author":"S Rasi","year":"2012","unstructured":"Rasi S, Monti S, Spina V, Fo\u00e0 R, Gaidano G, Rossi D. Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis. Haematologica. 2012;97(1):153\u20134.","journal-title":"Haematologica"},{"issue":"1","key":"1634_CR24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hon.2013","volume":"31","author":"M Greco","year":"2013","unstructured":"Greco M, Capello D, Bruscaggin A, et al. Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis. Hematol Oncol. 2013;31(1):54\u20135.","journal-title":"Hematol Oncol"},{"issue":"11","key":"1634_CR25","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","volume":"122","author":"A Ferrajoli","year":"2013","unstructured":"Ferrajoli A, Shanafelt TD, Ivan C, et al. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013;122(11):1891\u20139.","journal-title":"Blood"},{"key":"1634_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2013.08.003","volume":"24","author":"K Karube","year":"2014","unstructured":"Karube K, Scarf\u00f2 L, Campo E, Ghia P. Monoclonal B cell lymphocytosis and \u201cin situ\u201d lymphoma. Semin Cancer Biol. 2014;24:3\u201314.","journal-title":"Semin Cancer Biol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1634-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1634-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1634-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T16:34:18Z","timestamp":1598114058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1634-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,27]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["1634"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1634-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,27]]}}}